Stay updated on Ampion Therapy in Adult COVID-19 Patients Clinical Trial
Sign up to get notified when there's something new on the Ampion Therapy in Adult COVID-19 Patients Clinical Trial page.

Latest updates to the Ampion Therapy in Adult COVID-19 Patients Clinical Trial page
- Check6 days agoChange DetectedA banner announces updates to NIH websites and says federal agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check13 days agoChange DetectedThe site revision displayed in the footer changed from v3.7.1 to v3.7.2, while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check20 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1; the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check40 days agoChange DetectedThe study page displays a 403 Forbidden error, replacing the usual study details with an access-denied message. The changes insert the 403 content and remove many study-related sections, resulting in an inaccessible study entry.SummaryDifference17%

- Check62 days agoChange DetectedFooter revision tag updated from v3.6.5 to v3.6.6. This represents a deployment update to the ClinicalTrials.gov interface with no change to study data or content.SummaryDifference0.1%

- Check83 days agoChange DetectedThe page revision was updated from v3.6.4 to v3.6.5, indicating a minor maintenance update. There is no change to study data, layout, or available actions.SummaryDifference0.1%

Stay in the know with updates to Ampion Therapy in Adult COVID-19 Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ampion Therapy in Adult COVID-19 Patients Clinical Trial page.